IRIS
MAGLIANI, Valter
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.027
NA - Nord America 6.982
AS - Asia 2.730
Continente sconosciuto - Info sul continente non disponibili 19
AF - Africa 6
SA - Sud America 6
OC - Oceania 3
Totale 16.773
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.771
CN - Cina 2.537
IE - Irlanda 1.500
UA - Ucraina 1.465
DE - Germania 1.000
FI - Finlandia 903
SE - Svezia 868
IT - Italia 751
AT - Austria 304
CA - Canada 207
TR - Turchia 160
GB - Regno Unito 84
BE - Belgio 59
EU - Europa 19
FR - Francia 17
RO - Romania 17
ES - Italia 13
NL - Olanda 13
IN - India 12
CZ - Repubblica Ceca 11
BR - Brasile 5
ID - Indonesia 4
IL - Israele 4
EE - Estonia 3
EG - Egitto 3
HK - Hong Kong 3
IR - Iran 3
MX - Messico 3
NZ - Nuova Zelanda 3
PL - Polonia 3
SK - Slovacchia (Repubblica Slovacca) 3
CH - Svizzera 2
HU - Ungheria 2
LU - Lussemburgo 2
NG - Nigeria 2
NO - Norvegia 2
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
EC - Ecuador 1
JP - Giappone 1
KR - Corea 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
NP - Nepal 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 16.773
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.537
Dublin 1.498
Chandler 1.001
Dearborn 761
Beijing 739
Nanjing 480
Princeton 364
San Mateo 285
Ann Arbor 278
Vienna 255
Wilmington 206
Toronto 193
Ashburn 174
Bremen 166
Kunming 165
Shenyang 154
Hefei 149
Izmir 148
Parma 144
Nanchang 138
Hebei 117
Boardman 99
Des Moines 99
Jinan 88
Helsinki 72
Grafing 68
Jiaxing 61
Brussels 57
Tianjin 54
Woodbridge 51
Changsha 49
Norwalk 47
Guangzhou 46
Düsseldorf 37
Fremont 34
Hangzhou 27
Zhengzhou 27
Chengdu 24
Seattle 22
Rome 20
Fuzhou 19
Houston 16
Milan 16
Ningbo 16
Haikou 13
Reggio Nell'emilia 13
Torino 13
Kocaeli 12
Taiyuan 12
Taizhou 12
Wenzhou 12
Wuhan 12
Shaoxing 11
Auburn Hills 10
Florence 10
Modena 10
Redmond 10
Timisoara 10
Falls Church 9
Napoli 9
Redwood City 9
Verona 9
Rockville 8
Borås 7
Chongqing 7
Palermo 7
Washington 7
Xian 7
Bilbao 6
Catania 6
Philadelphia 6
Quzhou 6
Scottsdale 6
Baotou 5
Bologna 5
Chaoyang 5
Edinburgh 5
Fairfield 5
Munich 5
Rio Saliceto 5
Bari 4
Carpineti 4
Genova 4
Hanover 4
Horia 4
Jakarta 4
Jinhua 4
Leawood 4
Lugo 4
Martina Franca 4
Nürnberg 4
Shanghai 4
Vancouver 4
Vigevano 4
Arcevia 3
Bisenti 3
Bratislava 3
Brindisi 3
Brno 3
Cambridge 3
Totale 10.379
Salva come PNG Salva come JPEG
Nome #
Capitolo 5. Differenziamento reale e differenziamento temporaneo. 193
Cap. 6. Differenziamento reale e differenziamento temporaneo. 119
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 106
L'identificazione dei batteri Gram negativi mediante il sistema ATB. 104
Antifungal peptides within the antibodies 96
Anti-infective antibody-derived peptides active against endogenous and exogenous fungi 89
In vitro and in vivo anti-Candida activity and structural analysis of killer peptide (KP)-derivatives 86
Natural and synthetic peptides with antifungal activity 85
Screening of thiosemicarbazones as antimycotic drugs 84
Il sistema immunoenzimatico GM1 ELISA per la ricerca della tossina termolabile di E. coli. 83
Anti-septic shock recombinant vaccine. 83
Metabolic profiling of Candida albicans 82
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali 82
Antibodies as a source of anti-infective peptides: an update 81
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 81
Wickerhamomyces yeast killer toxins’ medical applications 80
Agenti virali di gastroenterite. 79
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 79
Significato diagnostico di IgA secretorie adese a cellule lievitiformi nelle candidosi orali 79
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 78
Antibodies as Crypts of Antiinfective and Antitumor Peptides 77
Peptides from the inside of the antibodies are active against infectious agents and tumours 77
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation 73
Production of an engineered killer peptide in Nicotiana benthamiana by using a Potato virus X expression system 72
Clonaggio e sequenziamento dei geni codificanti per la tossina killer di Pichia anomala 72
A synthetic peptide as a novel anticryptococcal agent 71
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 71
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 71
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 71
Antibody peptide based antifungal immunotherapy 70
Antibody-mediated protective immunity in fungal infections 70
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 69
Phenotypic modulation of porcine CD14+ monocytes, natural killer/natural killer T cells and CD8αβ+ T cell subsets by an antibody-derived killer peptide (KP) 69
Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins 69
Applicazioni della Biologia Molecolare in Micologia. 68
Valutazione di un nuovo sistema automatizzato per l'identificazione e l'antibiogramma: L'identificazione rapida. Workshop: Recenti sviluppi e nuove prospettive dei metodi automatizzati per l'identificazione e l'antibiogramma. 67
Antibiocorpi: anticorpi antiidiotipo ad attività antibiotica e profilattica. 67
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 67
Spettro d'azione universale di mimotopi killer antifungini 66
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. 66
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 66
Inibizione della replicazione di virus influenzali mediante trattamento di cellule infette con un peptide sintetico killer 65
Caratterizzazione dell'amikacina-resistenza in Acinetobacter calcoaceticus varietà anitratus. 64
Anticorpi antibiotici ricombinanti ad attività terapeutica fungicida. 64
Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies. 64
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 64
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis 63
Therapeutic potential of yeast killer toxin-like antibodies and mimotopes 63
Antibiobodies: antibiotic internal image antibodies 63
L'elettroferotipo come mezzo di indagine epidemiologica nelle gastroenteriti da rotavirus umani. 63
Fungicidal activity of peptides encoded by immunoglobulin genes 62
A peptide found in human serum, derived from the c-terminus of albumin, shows antifungal activity in vitro and in vivo 62
Anticorpi antibiotici antiidiotipo immagini interne di tossine killer. 62
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali aviari ed umani. 61
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 61
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity 60
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 60
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 60
Valutazione di alcuni aspetti della nuova tecnologia VITEK2 effettuata presso gli Istituti di Microbiologia dell'Università di Parma e dell'Università Cattolica di Roma. Workshop: VITEK2: un mondo d'innovazione. 60
Caratterizzazione di mannoproteine da stress di Candida albicans reattive con IgA secretorie 59
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 59
Attività protettiva di anticorpi killer anti-idiotipo nell’aspergillosi polmonare invasiva in un modello murino di trapianto di midollo osseo allogenico privo di linfociti T. 59
Indagini batteriologiche e virologiche su campioni di feci in pazienti affetti da gastroenterite acuta osservati presso gli Ospedali Riuniti di Parma. 58
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 58
Antireceptor yeast killer toxin-like antibiobodies 58
Any antibody fragment might exert antifungal activity 58
Immunizzazione neonatale nei confronti dell'infezione da streptococco di gruppo B mediante vaccini antiidiotipici ricombinanti. 57
Antibiotic assay-based treatment of Helicobacter Pylori ( HP ) infection. 57
Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food 57
Antimicrobial peptides with antiprotozoal activity: Current state and future perspectives 57
Engineered commensal bacteria as delivery systems of anti-infective mucosal protectants 57
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 57
Reliability of the bacterial identification tests and of antibiotic sensitivity tests made with automatic methods. 56
From Pichia anomala killer toxin through killer antibodies to killer peptides for a comprehensive anti-infective strategy 56
Restriction of Influenza virus multiplication induced by PK peptide treatment 56
Vaccine for the prevention of Aflatoxin B1 carry over in the milk of lactating dairy cows 56
Metabolic profile of Candida albicans 56
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 56
Les récepteurs des toxines killer de levure 55
Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides 55
Anticorpi antiidiotipici ricombinanti ad attività terapeutica fungicida. 55
Anticorpi immagini interne di tossine killer 55
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis 55
Antibiobodies: antibiotic-like antiidiotypic antibodies. 55
In silico predicted antifungal peptides: In vitro and in vivo anti-candida activity 55
Protective antifungal yeast killer toxin-like antibodies 54
Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria 54
Sintesi di RNA complementari e virali in cellule infettate con il virus dell'influenza. 54
Capitolo 6. Genetica dei microrganismi 54
Protective immunization against group B meningococci using anti-idiotypic mimics of the capsular polysaccharide 54
Recombinant Streptococcus gordonii for mucosal delivery of a scFv microbicidal antibody 54
In vitro activity of monoclonal and recombinant yeast killer toxin-like antibodies against antibiotic-resistant Gram-positive cocci 53
Caratterizzazione dell'amikacina-resistenza in Acinetobacter calcoaceticus varietà anitratus. 53
L'automazione integrata nel Laboratorio di Batteriologia. 53
Les toxines killer de levure 52
Vaccini antifungini. 52
Antibiotic resistance and antibiotic sensitivity based treatment in Helicobacter pylori infection: advantages and outcome. 52
Antifungal activity of the C-terminal peptide from human serum albumin 52
Automazione dell’antibiogramma diretto sulle urine. 52
Idiotypic antifungal vaccination: Immunoprotection by antiidiotypic antibiotic antibodies 52
Totale 6.706
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.198
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019766 0 0 0 0 0 304 22 29 103 18 257 33
2019/20204.963 767 985 333 116 462 494 571 119 372 315 105 324
2020/20212.301 10 322 310 25 336 27 325 21 478 44 351 52
2021/20221.627 24 4 17 61 51 86 224 300 66 107 157 530
2022/20234.784 590 377 218 285 472 511 75 243 1.789 32 116 76
2023/2024609 117 171 94 53 141 33 0 0 0 0 0 0
Totale 16.930